EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

Duration of the action is 72 months (end 31 Dec 2025)
Number of researchers is >100

UNIZAR/ARAID
Principal Investigators: Jose A. Aínsa & Santiago Ramón-García
Work Packages 2 (In vitro Profiling) Leaders.
WP2 includes 14 partners and a budget of ca. 20 million euros.

Acronym: 
ERA4TB
Author: 
Ramón García, Santiago
Principal researcher: 
Juan José Vaquero (Universidad Carlos III Madrid)
Managing entity: 
Otros
Scope: 
Internacional
Entidades participantes: 
UNIVERSIDAD CARLOS III DE MADRID (UC3M)
INSTITUT PASTEUR (IPP)
UNIVERSIDAD DE ZARAGOZA (UNIZAR)
INSTITUT PASTEUR DE LILLE FONDATION (IPL)
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (SYNAPSE)
FORSCHUNGSZENTRUM BORSTEL (FZB)
FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS (IM4TB)
CRITICAL PATH INSTITUTE, LIMITED (C-Path)
CONSIGLIO NAZIONALE DELLE RICERCHE (CNR)
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (CEA)
SERVICIO MADRILENO DE SALUD (SERMAS)
UPPSALA UNIVERSITET (UU)
Department of Health (PHE)
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
KLINIKUM DER UNIVERSITAET ZU KOELN (UHC)
UNIVERSITA DEGLI STUDI DI PADOVA (UNIPD)
UNIVERSITA DEGLI STUDI DI PAVIA (UPV)
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
IMABIOTECH SAS (IBT)
SCIENSANO (SCI)
LATVIJAS ORGANISKAS SINTEZES INSTITUTS (IOS)
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE (BAR)
QPS NETHERLANDS BV (QPS)
LUNDS UNIVERSITET (LUND)
GRITSYSTEMS AS (GRIT)
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL (GSK)
EVOTEC INTERNATIONAL GMBH (EVT)
JANSSEN PHARMACEUTICA NV (JANSSEN)
BILL & MELINDA GATES FOUNDATION (BMGF)
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION (TBA)
UNIVERSITY OF DUNDEE (UNIVDUN)
Number of researchers: 
100
Start date: 
01/2020
End date: 
12/2023
Entidad financiadora
Financing entity: 
European Commission H2020
Call: 
H2020-JTI-IMI2-2018-15-two-stage
Presupuesto
Total budget: 
89.815.600€